DekaBank Deutsche Girozentrale’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-7,400
| Closed | -$136K | – | 1149 |
|
|
2015
Q4 | $136K | Buy |
7,400
+1,100
| +17% | +$20.2K | ﹤0.01% | 929 |
|
|
2015
Q3 | $133K | Buy |
6,300
+300
| +5% | +$6.33K | ﹤0.01% | 936 |
|
|
2015
Q2 | $297K | Buy |
6,000
+200
| +3% | +$9.9K | ﹤0.01% | 805 |
|
|
2015
Q1 | $454K | Sell |
5,800
-750
| -11% | -$58.7K | 0.01% | 743 |
|
|
2014
Q4 | $389K | Sell |
6,550
-600
| -8% | -$35.6K | ﹤0.01% | 746 |
|
|
2014
Q3 | $305K | Buy |
7,150
+500
| +8% | +$21.3K | ﹤0.01% | 752 |
|
|
2014
Q2 | $411K | Buy |
6,650
+500
| +8% | +$30.9K | 0.01% | 644 |
|
|
2014
Q1 | $400K | Buy |
6,150
+500
| +9% | +$32.5K | 0.01% | 612 |
|
|
2013
Q4 | $323K | Buy |
5,650
+350
| +7% | +$20K | 0.01% | 604 |
|
|
2013
Q3 | $325K | Buy |
5,300
+350
| +7% | +$21.5K | 0.01% | 595 |
|
|
2013
Q2 | $298K | Buy |
+4,950
| New | +$298K | 0.01% | 494 |
|